Asparagine depletion after pegylatedE. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: A Children's Oncology Group study (CCG-1941)-Reference-Cited by-同舟云学术

Asparagine depletion after pegylatedE. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: A Children's Oncology Group study (CCG-1941)

Published:2006 Issue:2 Volume:47 Page:141-146
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Jarrar Mohammad,Gaynon Paul S.,Periclou Antonia P.,Fu Cecilia,Harris Richard E.,Stram Daniel,Altman Arnold,Bostrom Bruce,Breneman John,Steele David,Trigg Michael,Zipf Theodore,Avramis Vassilios I.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference42 articles.

1. Asparaginase and Cancer — Yesterday and Today

2. Nutritional effects on precursor uptake and compartmentalization of intracellular pools in relation to RNA synthesis

3. L-asparaginase kills lymphoma cells by apoptosis

4. Characterization of Apoptotic Phenomena Induced by Treatment with L-Asparaginase in NIH3T3 Cells

5. Cell cycle arrest and apoptosis of leukemia cells induced by L-asparaginase

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. l‐Asparaginase Bio‐Betters: Insight Into Current Formulations, Optimization Strategies and Future Bioengineering Frontiers in Anti‐Cancer Drug Development;Advanced Therapeutics;2024-08-19

2. The potential of methioninase for cancer treatment;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-07

3. L-asparaginase anti-tumor activity in pancreatic cancer is dependent on its glutaminase activity and resistance is mediated by glutamine synthetase;Experimental Cell Research;2023-05

4. RecombinantErwiniaasparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study;Blood;2023-02-16

5. Clinical Trials Involving Chemotherapy-Based Nanocarriers in Cancer Therapy: State of the Art and Future Directions;Cancer Nanotechnology;2022-12-14